Trade Summary
2 weeks ago, Frost Mark T, serving as CFO at Harvard Bioscience Inc (HBIO), purchased 5,000 shares at $5.00 per share, for a total transaction value of $25,000.00. Following this transaction, Frost Mark T now holds 17,500 shares of HBIO.
This purchase represents a 40.00% increase in Frost Mark T's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 1, 2026, 16 days after the trade was made.
Harvard Bioscience Inc operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
